| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.00035 | 1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.00023 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 3.3e-05 | 1 |